Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factorβ1, and activin a: Comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells
- 1 July 2000
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 32 (1), 26-35
- https://doi.org/10.1053/jhep.2000.8535
Abstract
A well characterized human cholangiocarcinoma (CC) cell line, SG231, was compared with primary cultures of normal human biliary epithelial cells (BECs) for alterations in interleukin 6 (IL-6) and hepatocyte growth factor (HGF)-mediated stimulation and transforming growth factor beta1 (TGF-beta1) and activin A-mediated inhibition of growth. Results were compared with immunolabeling of the original tumor and after injection of SG231 into the liver of BALB/cByJ-scid mice. In vitro, both BECs and CCs expressed met, gp80, and gp130 messenger RNA (mRNA) and protein, but the levels of expression were higher in the CCs than in the BECs. In both the CCs and BECs, exogenous HGF or IL-6 induced phosphorylation of met or gp130, respectively, and a concentration-dependent increase in DNA synthesis. However, the CCs but not BECs, continued to grow in basal serum-free medium (SFM) and spontaneously produced both IL-6 and HGF under these conditions, which resulted in auto-phosphorylation of gp130 and met, respectively; and neutralizing anti-HGF or anti-IL-6 alone inhibited CC growth, indicative of autocrine growth control circuits. Conversely, activin A inhibits the growth of both BECs and CCs, but does not significantly increase apoptosis. Activin-A-induced growth inhibition of both CCs and BECs can be reversed by 100 ng/mL exogenous IL-6, but not by 10 to 100 ng/mL HGF. TGF-beta1 inhibited the growth of BECs but had no mitoinhibitory or proapoptotic effects on CCs. Immunolabeling of the original tumor and after inoculation into scid mice showed positive staining for met, gp130, gp80, and IL-6. This study contributes to a further understanding of BEC growth control and derangements that can occur during cholangiocarcinogenesis.This publication has 40 references indexed in Scilit:
- Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated “intestinal-type” biliary cancer chemically induced in rat liverHepatology, 2000
- Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type i ductular reaction in mice: Interactions between the periductal inflammatory and stromal cells and the biliary epitheliumHepatology, 1998
- Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WB-F344 rat liver stem-like cellsHepatology, 1998
- Retinal Pigment Epithelial Cells Secrete and Respond to Hepatocyte Growth FactorBiochemical and Biophysical Research Communications, 1998
- Interleukin 6 and its Receptor: Ten Years LaterInternational Reviews of Immunology, 1998
- H441 Pulmonary Epithelial Cell Mitogenic Effects and Signaling Pathways in Response to Hgf and Tgf-αExperimental Lung Research, 1998
- Mutational Analysis of the p53 and K‐ras Genes and Allelotype Study of the Rb‐1 Gene for Investigating the Pathogenesis of Combined Hepatocellular‐Cholangiocellular CarcinomasJapanese Journal of Cancer Research, 1996
- Interleukin‐6 functions as an autocrine growth factor in a cholangiocarcinoma cell lineJournal of Gastroenterology and Hepatology, 1994
- Transforming growth factor-β1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the ratHepatology, 1994
- Chromosomal breakpoints in cholangiocarcinoma cell linesGenes, Chromosomes and Cancer, 1990